Company · CIK 0001119774 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
COMPUGEN LTD · CGEN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 AForm 4 → | Jul 30, 4:13 pm EDT | Zurit LevineSVP, Business Development | 18,000 | — | — | 47,375 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:11 pm EDT | David SilbermanChief Financial Officer | 19,500 | — | — | 55,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:08 pm EDT | Eran PerryDirector | 7,500 | — | — | 17,500 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:06 pm EDT | Russo Sharon KredoSVP, Research & Discovery | 18,000 | — | — | 37,500 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:05 pm EDT | Savitzky Kinneret LivnatDirector | 7,500 | — | — | 20,850 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:04 pm EDT | Mathias HukkelhovenDirector | 7,500 | — | — | 17,500 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:03 pm EDT | Gilead HalevyDirector | 7,500 | — | — | 18,907 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:02 pm EDT | Sanford S ZweifachDirector | 7,500 | — | — | 20,180 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:01 pm EDT | Michelle MahlerChief Medical Officer | 13,500 | — | — | 36,625 | — | |
| Jul 9, 2026 SForm 4 → | Jul 13, 4:01 pm EDT | Zurit LevineSVP, Business Development | 1,875 | $2.50 | $4,688 | 29,375 | −6.00% | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 13, 4:01 pm EDT | Zurit LevineSVP, Business Development | 1,875 | $0.8292 | $1,555 | 31,250 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 AForm 4 → | Jul 30, 4:13 pm EDT | Zurit LevineSVP, Business Development | 24,000 | — | — | 24,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:11 pm EDT | David SilbermanChief Financial Officer | 26,000 | — | — | 26,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:10 pm EDT | Eran OphirPresident and CEO, Director | 200,000 | — | — | 200,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:09 pm EDT | Anat Cohen-DayagDirector | 100,000 | — | — | 100,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:08 pm EDT | Eran PerryDirector | 10,000 | — | — | 10,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:07 pm EDT | Pierre FerreChief Operating Officer | 70,000 | — | — | 70,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:06 pm EDT | Russo Sharon KredoSVP, Research & Discovery | 24,000 | — | — | 24,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:05 pm EDT | Savitzky Kinneret LivnatDirector | 10,000 | — | — | 10,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:04 pm EDT | Mathias HukkelhovenDirector | 10,000 | — | — | 10,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:03 pm EDT | Gilead HalevyDirector | 10,000 | — | — | 10,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:02 pm EDT | Sanford S ZweifachDirector | 10,000 | — | — | 10,000 | — | |
| Jul 29, 2026 AForm 4 → | Jul 30, 4:01 pm EDT | Michelle MahlerChief Medical Officer | 18,000 | — | — | 18,000 | — | |
| Jul 9, 2026 MForm 4 → | Jul 13, 4:01 pm EDT | Zurit LevineSVP, Business Development | 1,875 | — | — | 3,750 | — | 10b5-1 |